These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 2191608)

  • 1. [Low density lipoprotein (LDL) heterogeneity and atherosclerosis].
    Dejager S; Cohen R; Bruckert E
    Ann Biol Clin (Paris); 1990; 48(3):154-60. PubMed ID: 2191608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atherogenic, dense low-density lipoproteins. Pathophysiology and new therapeutic approaches.
    Chapman MJ; Guérin M; Bruckert E
    Eur Heart J; 1998 Feb; 19 Suppl A():A24-30. PubMed ID: 9519339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Serum lipoprotein and atherogenicity--relationship with particle size and composition of low density lipoproteins, and their modifications by oxidation and glycation].
    Takeuchi N; Saheki S
    Rinsho Byori; 1995 Aug; 43(8):753-62. PubMed ID: 7474432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in LDL receptor-mediated metabolism of three low density lipoprotein subfractions by human monocyte-derived macrophages: impact on the risk for atherosclerosis.
    de Graaf J; Hendriks JC; Swinkels DW; Demacker PN; Stalenhoef AF
    Artery; 1993; 20(4):201-30. PubMed ID: 8250739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The low density lipoprotein and low density lipoprotein receptors and their possible importance in the pathogenesis of atherosclerosis.
    Dresel HA; Friedrich EA; Otto I; Waldherr R; Schettler G
    Arzneimittelforschung; 1985; 35(12A):1936-40. PubMed ID: 3913426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of modified oxidation of low density lipoprotein in pathognesis of atherosclerosis].
    Siennicka A; Zapolska-Downar D
    Postepy Hig Med Dosw; 2003; 57(2):219-37. PubMed ID: 12866357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low density lipoprotein-apheresis decreases oxidized low density lipoproteins and monocyte adhesion to endothelial cells.
    Cattin L; Petrucco A; Cazzolato G; Bon GB; Borelli V; Nardon E; Zabucchi G; Fonda M; Bordin P
    ASAIO J; 1997; 43(3):209-13. PubMed ID: 9152493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of oxidized low density lipoprotein with macrophages in atherosclerosis, and the antiatherogenicity of antioxidants.
    Aviram M
    Eur J Clin Chem Clin Biochem; 1996 Aug; 34(8):599-608. PubMed ID: 8877334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lipids, lipoproteins, arterial accidents and oral contraceptives].
    Bakir R; Hilliquin P
    Contracept Fertil Sex (Paris); 1986 Jan; 14(1):81-7. PubMed ID: 12341243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lipid peroxidation--the factor promoting cholesterol accumulation in cells in atherogenesis].
    Panasenko OM; Vol'nova TV; Azizova OA; Vladimirov IuA
    Biull Eksp Biol Med; 1988 Sep; 106(9):277-80. PubMed ID: 3167175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of dietary oxidized cholesterol and oxidized fatty acids in the development of atherosclerosis.
    Staprans I; Pan XM; Rapp JH; Feingold KR
    Mol Nutr Food Res; 2005 Nov; 49(11):1075-82. PubMed ID: 16270280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between low-density lipoprotein subclasses and asymptomatic atherosclerosis in subjects from the Atherosclerosis Risk in Communities (ARIC) Study.
    Hallman DM; Brown SA; Ballantyne CM; Sharrett AR; Boerwinkle E
    Biomarkers; 2004; 9(2):190-202. PubMed ID: 15370875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in dense LDL subfractions in normolipidemic IDDM patients.
    Rosental SB; Ferrari N; Ruiz M; Wikinski RL
    Acta Physiol Pharmacol Ther Latinoam; 1996; 46(3):185-92. PubMed ID: 9201319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inter-relationships between small, dense low-density lipoprotein (LDL), plasma triacylglycerol and LDL apoprotein B in an atherogenic lipoprotein phenotype in free-living subjects.
    Griffin BA; Minihane AM; Furlonger N; Chapman C; Murphy M; Williams D; Wright JJ; Williams CM
    Clin Sci (Lond); 1999 Sep; 97(3):269-76. PubMed ID: 10464051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ocimum basilicum ethanolic extract decreases cholesterol synthesis and lipid accumulation in human macrophages.
    Bravo E; Amrani S; Aziz M; Harnafi H; Napolitano M
    Fitoterapia; 2008 Dec; 79(7-8):515-23. PubMed ID: 18620033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The oxidative modification hypothesis of atherosclerosis: the comparison of atherogenic effects on oxidized LDL and remnant lipoproteins in plasma.
    Nakajima K; Nakano T; Tanaka A
    Clin Chim Acta; 2006 May; 367(1-2):36-47. PubMed ID: 16448638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A critical overview of the chemistry of copper-dependent low density lipoprotein oxidation: roles of lipid hydroperoxides, alpha-tocopherol, thiols, and ceruloplasmin.
    Burkitt MJ
    Arch Biochem Biophys; 2001 Oct; 394(1):117-35. PubMed ID: 11566034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimally oxidized LDL offsets the apoptotic effects of extensively oxidized LDL and free cholesterol in macrophages.
    Boullier A; Li Y; Quehenberger O; Palinski W; Tabas I; Witztum JL; Miller YI
    Arterioscler Thromb Vasc Biol; 2006 May; 26(5):1169-76. PubMed ID: 16484596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of microscopy in understanding atherosclerotic lysosomal lipid metabolism.
    Jerome WG; Yancey PG
    Microsc Microanal; 2003 Feb; 9(1):54-67. PubMed ID: 12597787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Atherogenicity of low-density lipoproteins (LDL). A problem of quantity or quality?].
    Dejager S; Turpin G
    Presse Med; 1995 Dec; 24(38):1772-6. PubMed ID: 8545426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.